Objective: Advocates for performing carotid endarterectomy (CEA) under regional anesthesia (RA) cite reduction in hemodynamic instability and the ability for neurologic monitoring, but many still prefer general anesthesia (GA) as benefits of RA have not been clearly demonstrated, reliable RA may not be available in all centers, and a certain amount of movement by the patient during the procedure may not be uniformly tolerated. We evaluated the association of anesthesia type and perioperative morbidity and mortality as well as resource utilization in patients undergoing CEA using the Michigan Surgical Quality Collaborative (MSQC) database.
Carotid endarterectomy (CEA) has long been the "gold standard" for critical carotid occlusive disease. CEA has traditionally been performed under general anesthesia (GA). Cooley et al reported in 1963 increased tolerance to cerebral ischemia produced by GA during temporary carotid occlusion and cross-clamping. 1 CEA under GA, however, requires methods for assessing adequate cerebral perfusion intraoperatively and surrogates for determining collateral blood flow. Carotid stump pressure measurement, electroencephalogram monitoring, or transcranial Doppler ultrasound checks are commonly used and shunts are selectively placed when inadequate perfusion is suggested. Others simply attempt to maintain ipsilateral cerebral perfusion by adopting the universal use of shunts.
In the 1960s, CEA under regional anesthesia (RA) was examined, allowing reliable monitoring of neurologic function and determination of the need for intraoperative selective carotid shunting. [2] [3] [4] The General Anesthesia versus Local Anesthesia for Carotid Surgery (GALA) trial in 2008 was recognized as a landmark study showing no difference in morbidity or mortality under local anesthesia vs GA. 5 The ideal anesthetic technique, however, has been the subject of intense study, with several studies reporting conflicting results and some suggesting a ahmadshussain@gmail.com).
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Copyright tendency toward increased cardiac morbidity with GA. [6] [7] [8] [9] Advocates for performing CEA under RA cite reduction in hemodynamic instability and indisputably reliable neurologic monitoring, but many still prefer to employ GA as benefits of RA have not been clearly demonstrated, reliable RA may not be available in all centers, and a certain amount of movement by the patient during the procedure may not be uniformly tolerated. The Michigan Surgical Quality Collaborative (MSQC) was formed in 2005 with an original cohort of 16 hospitals. Participation has grown steadily, with a total of 73 Michigan hospitals engaged in 2016. We evaluated the association of anesthesia type and perioperative morbidity and mortality as well as resource utilization in patients undergoing CEA using the MSQC database. This study is timely because of prominent Centers for Medicare & Medicaid Services initiatives tying reimbursement to specific quality measures.
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METHODS
We used clinical registry data from the MSQC. The study included cases with Current Procedural Terminology code 35301 and anesthesia in general, neuraxial or local/monitored anesthesia care, and an operation date between July 2012 and December 2014. We defined anesthesia technique as general or regional (neuraxial or local/monitored anesthesia care). The MSQC database does not contain a data field for indications for CEA, the surgeon's rationale for anesthesia choice, or cause of death. As such, asymptomatic and symptomatic subset analysis was not possible. Of the available fields, no fields had missing data points. All outcomes are for 30 days of follow-up after surgery. Reasons for readmission and emergency department (ED) visits were listed by International Classification of Diseases, Ninth Revision (ICD-9) code. Our Institutional Review Board approved the study, and informed consent was waived.
Statistics. We report statistical significance for differences in characteristics of the patients using the c 2 test. We adopted a two-stage modeling approach to test for the effect of anesthesia technique on selected outcomes of interest. For the stage-1 model, we used propensity score regression to control for differences in case mix between the two anesthesia groups. Propensity scores are widely used in observational research because they enable adjustment on a large number of covariates, thereby optimizing control for case mix. 13 In the stage-2 model, we used a mixed model with propensity scores and anesthesia technique as fixed effects and with site as a random effect. Modeling site as a random effect is necessary to account for clustering of cases by site. Through use of these two models, we were able to control for effects and to reach valid associated inferences. All analyses were performed using SAS 9.4 software (SAS Institute, Cary, NC).
RESULTS
Study data consisted of 4558 cases meeting inclusion criteria. Of these patients, 4008 underwent GA and 550 underwent RA. Table I lists the numbers of GA and RA by site. Whereas most sites use GA predominantly, as is consistent with national data, several sites in the collaborative use RA predominantly.
Patients' characteristics are listed in Table II. Table II is meant to highlight the unadjusted data in the study. Being a retrospective study, the populations studied are not homogeneous, and the patients' characteristics in the table are intended to be descriptive. The two groups were similar in gender and incidence of hypertension, diabetes, congestive heart failure, and smoking history. The RA group tended to be of better functional status, with there being more obese and partially dependent patients in the GA group. These differences in characteristics of the patients alone may suggest worse outcomes; the authors acknowledge that conclusion on the basis of unadjusted data and accounted for this with case mix adjustment.
Measures of association for outcomes for raw, unadjusted outcomes are listed in Table III Recommendation: This study supports the use of regional anesthesia for carotid endarterectomy for both patient outcomes and resource management.
(2.1% vs 0.6%), pneumonia (1.3% vs 0.0%), sepsis (0.8% vs 0.0%), and readmissions (9.2% vs 6.1%). Table IV lists results based on propensity score regression and the mixed model. Models were fit to evaluate the effect of anesthesia technique on outcomes and utilization. Adjusting for case mix and random effect, there was statistically significantly higher overall morbidity (P ¼ .0002), unplanned intubation (P ¼ .0196), extended length of stay (LOS; P ¼ .0007), ED visits (P ¼ .0379), and readmissions (P ¼ .0149) in the GA group. There was no statistically significant difference in incidence of myocardial infarction (MI) or cerebrovascular accident. Table IV does not report an adjusted odds ratio for mortality because of insufficient data.
The GA group had 325 (8.3%) ED visits and 361 (9.2%) readmissions. The RA group had 32 (6.0%) ED visits and 33 (6.1%) readmissions The top five reasons (including all ties) for ED visits and readmissions for the GA group are listed in Tables V and VI by 
DISCUSSION
In this study using the MSQC database of patients undergoing GA vs RA for CEA, we found several differences in outcomes. There was no statistically significant difference in the commonly analyzed end points of MI or stroke. A recent study of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) cohort by Hye et al showed increased periprocedural MI with GA vs RA. 9 Similarly, two studies of the National Surgical hemodynamics, carotid manipulation, vasoactive medications, and anesthetic agents, which all vary by provider (both surgeon and anesthesiologist), as well as the wide array of definitions of myocardial dysfunction used to track the outcomes, which include elevation of cardiac biomarkers, electrocardiogram changes, and overall clinical diagnosis. We did find a significant increase in any morbidity with GA. There was also a higher percentage of unplanned intubations after GA. The increase in overall morbidity after GA vs RA demonstrated is likely multifactorial. GA has been shown to be associated with cardiopulmonary and neurocognitive complications. 16, 17 Although the widespread use of GA speaks volumes of its safety, subtle changes may be impactful, especially in a population of patients whose care plan generally seeks early discharge. As far as the GA group having more unplanned reintubations, that point would be remarkable only if the converse were found to be the case (that is, if the RA group had been the one with more unplanned reintubations).
Findings related to resource utilization were similar to those reported by others with regard to LOS but also interesting with regard to outcomes such as ED visits and readmission. [18] [19] [20] [21] There was a significantly increased LOS with the GA group as well as a significant increase in ED visits and readmissions. The major reasons for readmission and ED visits appear to be procedure and carotid disease related. Comparatively, the top reasons for ED visits and readmission for the RA group were similarly related, but they appeared to be less frequent than in the GA group. ICD-9 codes on readmission suggestive of a procedure-related complication were selected less than half the time, as was the more "general" anatomic code in both groups. The results for readmission rates seem excessive but were similar to those of several studies evaluating readmission rates after CEA, including a study by Ho et al in 2014, in which they found an overall 30-day readmission rate of 8.6%. [22] [23] [24] When one postulates possible reasons for a patient who is receiving GA to be more likely to have postoperative neck swelling or a hematoma, in addition to operator differences like whether or not heparin is reversed at the end of the procedure, such things as bucking against the endotracheal tube during emergence from GA and the accompanying spikes in blood pressure that often occur during that same time come to mind. Unfortunately, in this retrospective review, no such data points are available to allow a deeper investigation into that question. Schechter et al also showed shorter operative and anesthesia times with RA vs GA for CEA as well as a higher likelihood to be discharged on postoperative day 1. 15 Several other studies have found decreased resource utilization with RA for CEA. These include the studies of Gabelman et al, who suggested a shorter hospital stay with RA; Ricotta et al, who showed cost savings with RA; and Papavasiliou et al, who demonstrated a shorter hospital stay with RA. [18] [19] [20] These findings were supported by our data and should translate into overall lower cost of care.
Resource utilization was further analyzed to include the incidence of ED visits and readmissions. Although cost data are not included in the study, increased resource utilization is a surrogate for cost. The implications that these findings might have on the ability to be competitive for value-based purchasing are compelling as Medicare and private insurance companies are increasingly moving toward this focus. 21 Our data suggest lower cost of care and less morbidity with RA vs GA for CEA.
This has implications for enterprise resource planning initiatives and the CEA value proposition in general, which is of special interest to both hospitals and payers. Limitations of this study include its retrospective nature. The provider's preferences as well as the patient's history and clinical circumstances influence anesthetic type used in CEA. Another limitation in the study is that we were unable to separate data for asymptomatic and symptomatic patients. Having data for "indications for CEA" would have allowed further appropriate subset analysis. Although a goal of the study was to account for differences in patient covariates and clustering by providers, there were clearly other relevant data points we would have included but had no access to in the data set.
CONCLUSIONS
Based on this analysis from the MSQC database, there is an associated increased morbidity and resource utilization with GA vs RA for CEA. Specifically, GA for CEA is significantly associated with any morbidity, unplanned intubation, extended LOS, ED visits, and readmission. These data support the use of RA for CEA both for patient outcomes and for resource management. The findings will continue to fuel the debate as to whether RA, when clinically appropriate, should be chosen preferentially over GA. 
